The Next Horizon of Improvement

"This is just, okay, oh, we're on the right track? Like this is doing something?" he asks. "I'm sure there's going to be some kind of... pushback ...in a closely scary about it." The drug could slow Alzheimer's down by 50% or 60%. It would cost $26,000 a year; big pharma might not like that. But if you get diagnosed at 70, most people survive 10-11 years after diagnosis.